Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions

Basit Öğe Kaydı
dc.authoridMiman, Murat Cem/0000-0002-2139-9239
dc.authoridOZTURAN, ORHAN/0000-0002-6129-8627
dc.authorwosidMiman, Murat Cem/AAZ-4873-2020
dc.authorwosidOZTURAN, ORHAN/B-4984-2015
dc.contributor.authorErdem, T
dc.contributor.authorOzturan, O
dc.contributor.authorMiman, MC
dc.contributor.authorOzturk, C
dc.contributor.authorKaratas, E
dc.date.accessioned2024-08-04T20:13:14Z
dc.date.available2024-08-04T20:13:14Z
dc.date.issued2003
dc.departmentİnönü Üniversitesien_US
dc.description26th National Congress of the Society-of-Otorhinolaryngology-and-Head-and-Neck-Surgery -- SEP 21-26, 2001 -- ANTALYA, TURKEYen_US
dc.description.abstractAlthough the relationship between hearing loss and hyperlipoproteinemia (HLP) or diabetes mellitus (DM) has been shown in many clinical investigations, this concept is still controversial. A prospective study was designed to search for the existence of subclinical auditory dysfunction related to HLP and DM by transient-evoked (TEOAEs) and distortion-product otoacoustic emissions (DPOAEs) in patients with hearing levels better than 30 dB. Evoked otoacoustic emissions were utilized to investigate subclinical auditory dysfunction. Fifteen hypercholesterolemic patients (28 ears), 21 hypertriglyceridemic patients (42 ears) and 21 DM patients (40 ears) were eligible for investigation. The results of the DPOAEs and TEOAEs of the study groups were compared with the control group composed of individuals with similar ages and with normal blood lipids and glycemia. This group consisted of 22 people (44 ears). There was no difference in the existence of TEOAEs at all frequencies among the groups (P>0.05). No differences were found in the amplitudes of the DPOAES between the groups except at 4 kHz (P>0.05). The difference was caused by the hypertriglyceridemia group (P=0.014) and the non-insulin-dependent diabetes mellitus (NIDDM) group (P=0.012) when compared with the control group. The mean DPOAE amplitudes of the hypertriglyceridemic and NIDDM groups at 4 kHz were higher, than those of the control group. The decreased DPOAE amplitudes at 4 kHz in hypertriglyceridemic and diabetic patients without clinical findings are compatible with the sensorineural hearing loss observed with hyperviscosity and increased noise susceptibility, as was shown before in these patients. Longitudinal investigations should be performed with otoacoustic emissions to help with the early prediction of the prospective effects of HLP and DM on the auditory system.en_US
dc.description.sponsorshipSoc Otorhinolaryngol Head Neck Surgen_US
dc.identifier.doi10.1007/s00405-002-0519-1
dc.identifier.endpage66en_US
dc.identifier.issn0937-4477
dc.identifier.issue2en_US
dc.identifier.pmid12582780en_US
dc.identifier.scopus2-s2.0-0037291071en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage62en_US
dc.identifier.urihttps://doi.org/10.1007/s00405-002-0519-1
dc.identifier.urihttps://hdl.handle.net/11616/93487
dc.identifier.volume260en_US
dc.identifier.wosWOS:000181666200002en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer-Verlagen_US
dc.relation.ispartofEuropean Archives of Oto-Rhino-Laryngologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjecthyperlipoproteinemiaen_US
dc.subjectdiabetes mellitusen_US
dc.subjectauditory functionsen_US
dc.subjecthearing lossen_US
dc.subjectotoacoustic emissionsen_US
dc.subjectnoise susceptibilityen_US
dc.titleExploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissionsen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu